Citations

Clear

2303 citation(s) found for "Yu, Edward".

HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Roy, Debarshi , Camacho-Pereira, Juliana , Khurana, Ashwani, Chini, Eduardo N. , Yang, Lifeng , Baddour, Joelle, Stilles, Katherine, Padmabandu, Seth, Leung, Sam, Lowe, Val J. , Dierks, Thomas , Hammond, Edward , Dredge, Keith , Nagrath, Deepak , Shridhar, Viji , Mondal, Susmita, Chini, Eduardo, Mondal, Susmita , Kalloger, Steve E. , Gilks, C. Blake

Mayo Clinic

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 32 | Pages: 33705-33719

10.18632/oncotarget.5605 | PMID 26378042 Get It

A functional variant in HOXA11-AS , a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer
Richards, Edward J., Permuth‐Wey, Jennifer, Li, Yajuan , Coppola, Domenico , Reid, Brett M. , Lin, Hui‐Yi , Teer, Jamie K. , Birrer, Michael J. , Lawrenson, Kate , Monteiro, Álvaro N.A. , Schildkraut, Joellen M. , Goode, Ellen L. , Gayther, Simon A. , Sellers, Thomas A. , Cheng, Jin Q. , Chen, Y. Ann , Berchuck, Andrew , Lawrenson, Kate , Monteiro, Alvaro N , Lin, Hui-Yi

Mayo Clinic

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 33 | Pages: 34745-34757

10.18632/oncotarget.5784 | PMID 26430965 Get It

Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice
Zhi, Xu , Berryman, Darlene E. , Kopchick, John J. , Gesing, Adam , Fang, Yimin , Stout, Michael B, Stout, Michael B , Swindell, William R. , Rohde, Kyle H. , List, Edward Owen , Masternak, Michal M

Mayo Clinic

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 29 | Pages: 26702-26715

10.18632/oncotarget.5760 | PMID 26436954 Get It

Accuracy of annual prescription drug expenditure forecasts inAJHP
Hartke, Patricia, Vermeulen, Lee C. , Hoffman, James M. , Shah, Nilay D. , Doloresco, Fred, Suda, Katie J. , Li, Edward C., Matusiak, Linda M., Hunkler, Robert J., Schumock, Glen T., Hartke, Patricia L

Mayo Clinic

American Journal of Health-System Pharmacy | September 18, 2015 | Volume: 72 | Issue: 19 | Pages: 1642-1648

10.2146/ajhp140850 | PMID 26386105 Get It

Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis - authors' reply
Felice, Kara M. De, Loftus, Edward V. , Khanna, Sahil , Gupta, Arjun , Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 16, 2015 | Volume: 42 | Issue: 8 | Pages: 1032-1033

10.1111/apt.13373 | PMID 26374261 Get It

The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
Jung, Deok‐Beom , Yun, Miyong , Kim, Eun-Ok , Kim, Bonglee , Wang, Enfeng , Hammond, Edward , Dredge, Keith , Shridhar, Viji , Kim, Sung‐Hoon , Kim, Jaekwang , Jung, Ji Hoon , Mukhopadhyay, Debabrata

Mayo Clinic

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 7 | Pages: 4992-5004

10.18632/oncotarget.3214 | PMID 25669977 Get It

Sorting nexin 9 differentiates ligand-activated Smad3 from Smad2 for nuclear import and transforming growth factor β signaling
Wilkes, Mark C. , Repellin, Claire E. , Kang, Jeong Han , Andrianifahanana, Mahefatiana, Yin, Xueqian , Leof, Edward B.

Mayo Clinic

Molecular Biology of the Cell | September 3, 2015 | Volume: 26 | Issue: 21 | Pages: 3879-3891

10.1091/mbc.e15-07-0545 | PMID 26337383 Get It

Transforming growth factor β (TGFβ) is a pleiotropic protein secreted from essentially all cell types and primary tissues. While TGFβ’s actions reflect the activity of a number of signaling networks, the primary mediator of TGFβ responses are the Smad proteins. Following receptor activation, these cytoplasmic proteins form hetero-oligomeric complexes that translocate to the nucleus and affect gene transcription. Here, through biological, biochemical, and immunofluorescence approaches, sorting nexin 9 (SNX9) is identified as being required for Smad3-dependent responses. SNX9 interacts with phosphorylated (p) Smad3 independent of Smad2 or Smad4 and promotes more rapid nuclear delivery than that observed independent of ligand. Although SNX9 does not bind nucleoporins Nup153 or Nup214 or some β importins (Imp7 or Impβ), it mediates the association of pSmad3 with Imp8 and the nuclear membrane. This facilitates nuclear translocation of pSmad3 but not SNX9.
Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
Berbari, Elie F. , Kanj, Souha S. , Kowalski, Todd J., Darouiche, Rabih O., Widmer, Andreas F. , Schmitt, Steven , Hendershot, Edward F. , Holtom, Paul, Huddleston, P.M. , Petermann, Gregory W., Osmon, Douglas R. , Huddleston, Paul M, Kanj, Souha S , Huddleston, Paul M

Mayo Clinic

Clinical Infectious Diseases | August 27, 2015 | Volume: 61 | Issue: 6 | Pages: 859-863

10.1093/cid/civ633 | PMID 26316526 Get It

Abstract These guidelines are intended for use by infectious disease specialists, orthopedic surgeons, neurosurgeons, radiologists, and other healthcare professionals who care for patients with native vertebral osteomyelitis (NVO). They include evidence and opinion-based recommendations for the diagnosis and management of patients with NVO treated with antimicrobial therapy, with or without surgical intervention.
Genome-Wide Association Study of Prostate Cancer–Specific Survival
Szulkin, Robert , Whitington, Thomas, Aly, Markus , Grönberg, Henrik , Eeles, Rosalind A. , Easton, Douglas F. , Olama, Ali Amin Al , Benlloch, Sara, Muir, Kenneth , Giles, Graham G. , Southey, Melissa C. , FitzGerald, Liesel M. , Henderson, Brian E., Schumacher, Fredrick R. , Haiman, Christopher A. , Sipeky, Csilla , Tammela, Teuvo L.J. , Nordestgaard, Børge G. , Travis, Ruth C. , Neal, David E. , Donovan, Jenny , Hamdy, Freddie C. , Pashayan, Nora , Stanford, Janet L. , Thibodeau, Stephen N. , McDonnell, Shannon K. , Schaid, Daniel J. , Maier, Christiane, Vogel, Walther , Luedeke, Manuel, Herkommer, Kathleen , Kibel, Adam S. , Lubiński, Jan , Kluźniak, Wojciech , Cannon‐Albright, Lisa , Brenner, Hermann , Herrmann, Volker, Holleczek, Bernd , Sellers, Thomas A. , Lim, Hui-Yi, Kaneva, Radka , Mitev, Vanio , Teixeira, Manuel R. , Paulo, Paula , Maia, Sofia , Pandha, Hardev , Michael, Agnieszka , Batra, Jyotsna , Clements, Judith A. , BioResource, on behalf of the Australian Prostate Cancer, Albanes, Demetrius, Andriole, Gerald L. , Berndt, Sonja I., Gapstur, Susan M. , Giovannucci, Edward L. , Ma, Jing , Mondul, Alison M. , Stampfer, Meir J. , Stevens, Victoria L. , Weinstein, Stephanie J. , Trichopoulou, Antonia , Bueno-de-Mesquita, Bas H., Tjønneland, Anne , Cox, David G. , Mæhle, Lovise, Schleutker, Johanna , Lindström, Sara , Karlsson, Robert , Kote‐Jarai, Zsofia , Key, Tim , Pharoah, Paul D.P. , Khaw, Kay‐Tee , Cybulski, Cezary , Park, Jong Y. , Slavov, Chavdar , Spurdle, Amanda B. , Kierzek, Andrzej , BioResource, on behalf of the Australian Prostate Cancer, Berndt, Sonja I. , Chanock, Stephen Jacob , Hunter, David J. , Kraft, Peter , Marchand, Loı̈c Le , Penney, Kathryn , Wiklund, Fredrik E. , Giles, Graham G , Teixeira, Manuel R , Eeles, Rosalind A , Southey, Melissa C , Tjønneland, Anne , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Travis, Ruth C , Pashayan, Nora , Cannon-Albright, Lisa A , Michael, Agnieszka , Brenner, Hermann , Batra, Jyotsna , Clements, Judith , Lubinski, Jan , McDonnell, Shannon K

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 25, 2015 | Volume: 24 | Issue: 11 | Pages: 1796-1800

10.1158/1055-9965.epi-15-0543 | PMID 26307654 Get It

Abstract Background: Unnecessary intervention and overtreatment of indolent disease are common challenges in clinical management of prostate cancer. Improved tools to distinguish lethal from indolent disease are critical. Methods: We performed a genome-wide survival analysis of cause-specific death in 24,023 prostate cancer patients (3,513 disease-specific deaths) from the PRACTICAL and BPC3 consortia. Top findings were assessed for replication in a Norwegian cohort (CONOR). Results: We observed no significant association between genetic variants and prostate cancer survival. Conclusions: Common genetic variants with large impact on prostate cancer survival were not observed in this study. Impact: Future studies should be designed for identification of rare variants with large effect sizes or common variants with small effect sizes. Cancer Epidemiol Biomarkers Prev; 24(11); 1796–800. ©2015 AACR.